Long-Term Results of Cryoablation with a New Cryoprobe to Eliminate Chronic Atrial Fibrillation Associated with Mitral Valve Disease |
| |
Authors: | HIROSHI TADA,SACHIKO ITO,SHIGETO NAITO,YUTAKA HASEGAWA&dagger ,KENJI KUROSAKI,MASAHIKO EZURE&dagger ,TATSUO KANEKO&dagger ,SHIGERU OSHIMA,KOICHI TANIGUCHI, AKIHIKO NOGAMI&Dagger |
| |
Affiliation: | From the Division of Cardiology, Gunma Prefectural Cardiovascular Center, Maebashi, Gunma;, Cardiovascular Surgery, Gunma Prefectural Cardiovascular Center, Maebashi, Gunma;, and Division of Cardiology, Yokohama Rosai Hospital, Yokohama, Kanagawa, Japan |
| |
Abstract: | The purpose of this study was to examine the performance of a new cryoprobe in the treatment of chronic atrial fibrillation (AF) associated with mitral valve disease. The study included 66 patients undergoing mitral valve replacement. The mean AF duration was 9.0 ± 9.0 years and mean left atrial (LA) was diameter 57 ± 10 mm. Cryoablation (−60°C) was applied to four pulmonary vein (PV) orifices over 2–3 minute. The spherical tip (2-cm in diameter) of the cryoprobe is capable of ablating the left atrium near the PV, as well as the PV ostium with a single cryoablation. After cryoablation, mitral valve surgery or a combined surgical procedure were performed in 66 patients. There were no intraoperative complications. Sinus rhythm was restored in 60 patients (91%) immediately after the operation. Recurrent AF was treated with antiarrhythmic drugs and/or direct current cardioversion in 43 patients (72%). At discharge, 48 patients (72%) were in sinus rhythm. During a mean follow-up period of 31 ± 16 months, 40 patients (61%) were in sinus rhythm with (29) or without antiarrhythmic drugs (11). In patients in sinus rhythm at the end of the follow-up period, the duration of preoperative AF duration was significantly shorter (P < 0.05) and the preoperative LA diameter and cardiothoracic ratio were significantly smaller than in patients who were in AF (both for P < 0.005). Using this new cryoprobe, sinus rhythm was restored and maintained in 61% of patients with chronic AF and mitral valve disease with a 12–15 minute cryoablation procedure. |
| |
Keywords: | cryoablation atrial fibrillation mitral valve disease pulmonary vein |
|
|